Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Long-term postmenopausal hormone use, obesity, and fat distribution in older women

Article Abstract:

Hormone therapy in postmenopausal women does not appear to be associated with weight gain or obesity, though women who use such therapy tend to be less obese initially. Researchers interviewed and analyzed height, weight, fat distribution, and body composition in 671 postmenopausal women. The women were evaluated at an initial visit and a follow-up visit 15 years later. Of the women, 194 never used hormone therapy, 331 used it intermittently, and 146 used it continuously between visits. The most common hormone taken was estrogen, though progestin was also taken. At the initial visit, women who continuously received hormones were significantly less obese, after adjustment for age. At follow-up, there were no significant differences between the groups in obesity, fat distribution, or body composition after adjustment for age and initial obesity. Differences were also insignificant with adjustment for tobacco and alcohol consumption, exercise, health behavior, and characteristics of menopause.

Author: Barrett-Connor, Elizabeth, Kritz-Silverstein, Donna
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
Risk factors, Obesity, Aged women, Elderly women

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Of designer drugs, magic bullets, and gold standards

Article Abstract:

It may be premature to prescribe the drug raloxifene for postmenopausal women. This drug is similar to estrogen but does not adversely affect the breast or endometrium. A 1998 study found that raloxifene reduced LDL, or 'bad' cholesterol as much as hormone therapy with estrogen and progestin but did not raise HDL, or 'good' cholesterol as much. It has not been convincingly shown that estrogen replacement therapy reduces mortality rates from heart disease and there is even less data on raloxifene and a similar drug, tamoxifen.

Author: Rifkind, Basil M., Rossouw, Jacques E.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Editorial, Coronary heart disease, Estrogen, Estrogen antagonists

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis

Article Abstract:

Hormone replacement therapy may reduce the risk of dementia, according to researchers who analyzed 29 studies on the subject. However, many of the studies were not well-designed so further research may be needed on this topic.

Author: Nelson, Heidi D., LeBlane, Erin S., Janowsky, Jeri, Benjamin, K. S.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Dementia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Hormone therapy, Prevention
Similar abstracts:
  • Abstracts: Personal use of postmenopausal hormone replacement therapy by women physicians in the United States. Hormones to prevent coronary disease in women: when are observational studies adequate evidence?
  • Abstracts: The central role of obesity (hyperinsulinemia) in the pathogenesis of polycystic ovary syndrome. Role of androgens in the growth of endometrial carcinoma: an in vivo animal model
  • Abstracts: Early neonatal mortality and cesarean delivery in Mexico City. Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies
  • Abstracts: Ostrich fern poisoning - New York and western Canada, 1994. Amanita phalloides mushroom poisoning - Northern California, January 1997
  • Abstracts: Empirical Evidence of Design-Related Bias in Studies of Diagnostic Tests. Magnetic Resonance Angiography for the Evaluation of Lower Extremity Arterial Disease: A Meta-analysis
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.